Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sarcomas
Biotech
ADC biotech adds on $135M series B
TCGX led Adcendo's oversubscribed series B financing, with several existing investors—including RA Capital Management and Novo Holdings—in tow.
Gabrielle Masson
Nov 25, 2024 7:00am
Adaptimmune's cell therapy hits key goal in pivotal sarcoma test
Nov 13, 2024 2:57pm
FDA frees Salarius’ rare cancer asset from clinical hold
May 9, 2023 11:20am
Salarius pauses enrollment of sarcoma trial after patient death
Oct 18, 2022 9:50am
Adaptimmune's T-cell therapy clears efficacy bar in solid tumors
Nov 12, 2021 7:05am
ASCO: Adaptimmune’s cell therapy shrinks 39% of rare sarcomas
May 19, 2021 5:00pm
